Article: TOSITUMOMAB.(review status)(Brief Article)

Coulter Pharmaceutical Inc. and SmithKline Beecham have received priority review status from FDA for Bexxar (tositumomab, iodine I 131 ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!